Delivery Order SPE2DR25D1053-SPE2DR26FT871
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Envarsus XR 4 mg tablets (100-count packages) with a contract ceiling value of $1,711.95. This firm fixed-price delivery order, which has an ultimate completion date of October 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Envarsus XR 4 mg tablets (100 count) with a contract value of $6,847.80. This competitively awarded, non-set-aside delivery order is classified as firm fixed price and will be completed by October 6, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units) with a ceiling value of $3,608.26. This is a firm fixed-price delivery order with no set-aside designation, placing performance in Conshohocken, Pennsylvania, and scheduled for completion by December 3, 2025. The award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Envarsus XR 4 mg tablets (100 count) with a contract value of $4,283.14 and an ultimate completion date of September 9, 2025. This is a firm fixed price delivery order issued under a non-set-aside competitive procurement. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $4,712.76. The contract is scheduled for completion by October 7, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order represents a non-set-aside, competitively awarded procurement and is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Envarsus XR 1 mg tablets in a quantity of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,718.48 with firm fixed pricing and is scheduled for completion by September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Envarsus XR 1 mg tablets (100-count units) with a ceiling value of $1,718.48. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is expected to be completed by November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Envarsus XR 4 mg tablets (100 count) with a ceiling value of $5,135.82. This firm fixed-price, competitively awarded delivery order is scheduled for completion by November 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's existing pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Envarsus XR 1 mg tablets in a quantity of 100s, with a ceiling value of $1,718.48 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract that will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 15, 2025. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Envarsus XR 0.75 mg tablets (100 count) with a ceiling value of $2,037.96 and a firm fixed price structure. This delivery order is non-competitive and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT871Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Envarsus XR 4 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order valued at $5,412.39, with performance to be completed by December 5, 2025, at the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA IDC enables it to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains to support Defense Health Agency requirements and other federal healthcare customers worldwide. This specific delivery order for Envarsus XR, an immunosuppressant medication, aligns with AmerisourceBergen's established role as a primary pharmaceutical supplier for federal military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 11/13/25 |